Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink
Muscle & Nerve · 2025-02 · 71 (2) · 229-236
DOI: 10.1002/mus.28308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 16.12.2024. Verfasst von Rotana Alsaggaf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U…. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Cause of Death. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural Program of the National Cancer Institute, USA, Canada Foundation for Innovation, Canadian Institutes of Health Research and Muscular Dystrophy Canada.
Abstract (Originalsprache)
Introduction/Aim Patients with myotonic dystrophy type1 (DM1) have reduced lifespan. This study aimed to quantify mortality risks, and evaluate causes and time trends in DM1.
Methods
We identified 1021 DM1 patients and 15,104 matched DM1‐free controls from the United Kingdom (UK) Clinical Practice Research Datalink. We used Cox proportional hazards regression models to assess differences in all‐cause or cause‐specific mortality between DM1 patients and matched controls, and computed standardized mortality ratios (SMRs) for comparisons of DM1 patients with the UK general population.
Results
DM1 patients were at higher risk of death compared with matched DM1‐free controls (hazard ratio [HR] = 2.9, 95% confidence interval [CI] = 2.5–3.4) or the general UK population (SMR = 8.1, 95% CI = 7.3–9.1). The excess risk was primarily attributed to deaths from respiratory failure (HR = 26.7, p < 0.001), aspiration pneumonia (HR = 15.8, p < 0.001), arrythmia, and conduction defects (HR = 15.7, p < 0.001). No mortality risk difference between DM1 patients and matched DM1‐free cohort was noted for all cancers combined ( p = 0.52). No significant calendar time‐related changes in overall survival were seen for DM1 patients ( p trend = 0.19). In mortality cause‐specific analysis, and compared with patients diagnosed before 1993, death from cancer was on the rise (HR = 2.35, and 5.82 for patients diagnosed 1993–2003, and 2004–2016).
Discussion
Most DM1 patients died of known disease complications. This highlights the need for integrated clinical approaches with more careful and frequent monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Biostatistics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Children's Hospital of Eastern Ontario Research Institute, Division of Neurology, Department of Medicine, The Ottawa Hospital, and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.
ORCID-Profile: Shahinaz M Gadalla
Förderung
- Intramural Program of the National Cancer Institute, USA
- Canada Foundation for Innovation
- Canadian Institutes of Health Research and Muscular Dystrophy Canada
- Intramural NIH HHS
- Canada Research Chairs Program (Canada Research Chair in Neuromuscular Genomics and Health)
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Alsaggaf, R., Pfeiffer, R. M., Pearce, E. E., Greene, M. H., Lochmuller, H., & Gadalla, S. M. (2025). Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink. Muscle & Nerve, 71(2), 229-236. https://doi.org/10.1002/mus.28308
Vancouver
Alsaggaf R, Pfeiffer RM, Pearce EE, Greene MH, Lochmuller H, Gadalla SM. Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink. Muscle & Nerve. 2025;71(2):229-236. doi:10.1002/mus.28308
BibTeX
@article{Alsaggaf2025,
author = {Alsaggaf, Rotana and Pfeiffer, Ruth M and Pearce, Emily E and Greene, Mark H and Lochmuller, Hanns and Gadalla, Shahinaz M},
title = {Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink},
journal = {Muscle & Nerve},
year = {2025},
volume = {71},
number = {2},
pages = {229--236},
doi = {10.1002/mus.28308}
}
EUVIMED